Stem cell therapy company Juventas encouraged by heart failure trial
Regenerative medicine company Juventas Therapeutics is touting the results from 12-month data of a phase 1 clinical trial of heart failure patients. At 12 months, heart failure patients treated with the company’s stem cell therapy showed “significant” improvements in two key measures — a six-minute distance-walking test, as well as the Minnesota Living with Heart Failure [...]
[Read the full article here]Related News:
Stem Cells Work in Heart Failure Trial
Stem Cell Therapy Shows Promise For Heart Failure Patients, Study Shows
Stem cells cure heart failure? What “breakthrough” study shows